Send to

Choose Destination
Bioorg Med Chem. 2007 Feb 15;15(4):1638-44. Epub 2006 Dec 13.

A simple, yet highly accurate, QSAR model captures the complement inhibitory activity of compstatin.

Author information

Department of Chemical Engineering and Materials Science, and the Digital Technology Center, University of Minnesota, Minneapolis, MN 55455, USA.


Compstatin is a 13-residue cyclic peptide inhibitor of complement activation that was originally identified through phage-mediated presentation of a peptide library to C3b. Recent efforts to improve its activity have led to a rich dataset of complement analogs, with the most active analog being approximately 260 times more active than the parent compstatin. In the present work, a highly transparent quantitative structure-activity relationship model (Radj2=0.89) with four parameters is presented that captures important physico-chemical and geometrical properties of the analog molecules with regard to activity. The number of aromatic bonds and hydrophobicity of the fourth residue of compstatin correlated strongly with activity. Also important were the hydrophobic patch size near the disulfide bond and the solvent-accessible surface area occupied by nitrogen atoms of basic amino acid residues.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center